These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3520829)

  • 21. [Induction of cellular differentiation in the treatment of acute leukemias: preliminary report of the use of low doses of cytosine arabinoside for the induction of remission].
    Marín-López A; Lobato-Mendizábal E; Munive-Ordóñez I; Ruiz-Argüelles GJ
    Rev Invest Clin; 1984; 36(3):247-51. PubMed ID: 6515157
    [No Abstract]   [Full Text] [Related]  

  • 22. Retinoids as preventive and therapeutic anticancer agents (Part II).
    Lippman SM; Kessler JF; Meyskens FL
    Cancer Treat Rep; 1987 May; 71(5):493-515. PubMed ID: 3552220
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of 12-O-tetradecanoylphorbol-13-acetate on the proliferation and differentiation of normal and leukemic myeloid progenitor cells.
    Ozawa K; Miura Y; Hashimoto Y; Kimura Y; Urabe A; Takaku F
    Cancer Res; 1983 May; 43(5):2306-10. PubMed ID: 6831455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyfunctional cytokines: IL-6 and LIF. Introduction.
    Metcalf D
    Ciba Found Symp; 1992; 167():1-4. PubMed ID: 1425007
    [No Abstract]   [Full Text] [Related]  

  • 25. Complications of cytostatic therapy in childhood leukemia.
    Thunold S; Moe PJ
    Acta Pathol Microbiol Scand Suppl; 1973; 236():84-96. PubMed ID: 4521321
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of recombinant human granulocyte colony stimulating factor following high-dose cytosine arabinoside therapy in children with malignancy].
    Osugi Y; Keisei KH; Murayama N; Inoue M; Ishihara S; Hara J; Yagi K; Tawa A; Okada S; Izumi Y
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1379-82. PubMed ID: 2369140
    [No Abstract]   [Full Text] [Related]  

  • 27. Differentiation therapy in myelodysplastic syndromes.
    Morosetti R; Koeffler HP
    Semin Hematol; 1996 Jul; 33(3):236-45. PubMed ID: 8819233
    [No Abstract]   [Full Text] [Related]  

  • 28. Colony-stimulating factors in acute leukemia: will we ever have an answer?
    Finley RS
    Ann Pharmacother; 2001 Jan; 35(1):120-2. PubMed ID: 11197572
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term effect of a tumor promoter, 12-O-tetradecanoylphorbol-13-acetate, on induced differentiation of Friend leukemia cells.
    Yamasaki H; Saint-Vincent L; Martel N
    Cancer Res; 1980 Oct; 40(10):3780-5. PubMed ID: 7438061
    [No Abstract]   [Full Text] [Related]  

  • 30. Atypical retinoids: an expanding series of anti-leukemia and anti-cancer agents endowed with selective apoptotic activity.
    Garattini E; Terao M
    J Chemother; 2004 Nov; 16 Suppl 4():70-3. PubMed ID: 15688615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of cytarabine prodrugs and delivery systems for leukemia treatment.
    Chhikara BS; Parang K
    Expert Opin Drug Deliv; 2010 Dec; 7(12):1399-414. PubMed ID: 20964588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myelodysplasia: clinical and morphological aspects and treatment.
    Geary CG
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():138-40. PubMed ID: 2653491
    [No Abstract]   [Full Text] [Related]  

  • 33. Study of differentiation of fresh human leukemic cells by low dose cytosine arabinoside (LD Ara-C) and 12-O-tetradecanoylphorbol-13-acetate (TPA).
    Kuliczkowski K; Noworolska A; Frydecka I; Sedek K; Harłozińska A
    Neoplasma; 1989; 36(5):589-97. PubMed ID: 2812152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of DAAS derivatives and their enhancement of HL-60 leukemia cell differentiation.
    Kim SH; Chung SY; Kim YW; Kim TS; Choi BG
    Arch Pharm Res; 2008 Mar; 31(3):300-4. PubMed ID: 18409041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Progress in the treatment of acute leukemias].
    Popescu ER; Butoianu E; Nicoară ST
    Med Interna (Bucur); 1969 Sep; 21(9):1037-49. PubMed ID: 5378236
    [No Abstract]   [Full Text] [Related]  

  • 36. Dolastatin 10 and dolastatin 15: effects of two natural peptides on growth and differentiation of leukemia cells.
    Steube KG; Grunicke D; Pietsch T; Gignac SM; Pettit GR; Drexler HG
    Leukemia; 1992 Oct; 6(10):1048-53. PubMed ID: 1405759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the cytotoxicity of cytosine arabinoside.
    Haanen C; Muus P; Raymakers R; Drenthe-Schonk A; Salden M; Wessels J
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):120-9. PubMed ID: 3892698
    [No Abstract]   [Full Text] [Related]  

  • 38. Toward the development of innovative bifunctional agents to induce differentiation and to promote apoptosis in leukemia: clinical candidates and perspectives.
    Vizirianakis IS; Chatzopoulou M; Bonovolias ID; Nicolaou I; Demopoulos VJ; Tsiftsoglou AS
    J Med Chem; 2010 Oct; 53(19):6779-810. PubMed ID: 20925433
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of acute leukemia with 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine hydrochloride (cyclocytidine) (author's transl)].
    Masaoka T; Hasegawa Y; Tatsumi N; Nakamura H; Yoshitake J
    Rinsho Ketsueki; 1973 Aug; 14(8):877-81. PubMed ID: 4797128
    [No Abstract]   [Full Text] [Related]  

  • 40. Cancer combination chemotherapy with retinoids: experimental rationale.
    Bollag W; Majewski S; Jablonska S
    Leukemia; 1994 Sep; 8(9):1453-7. PubMed ID: 7522288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.